Onco-logic trials play a key role in moving cancer research forward, assessing new treatments, and enhancing patient outcomes. The session "Oncology Trials" concentrates on study design, study conduct, and study results of clinical trials which promote innovation in the treatment of cancer.".
These studies evaluate the safety, efficacy, and best use of emerging drugs, immunotherapies, targeted therapies, and combination regimens. They are crucial evidence for their adoption in clinical practice and guide treatment guidelines. Biomarker-guided investigations and precision medicine strategies enable identification of patients who are most likely to benefit, making trials more efficient and therapeutic more successful.
The workshop discusses new trial designs, such as adaptive trials, umbrella and basket studies, and integrating real-world evidence. Ethical oversight, patient recruitment approaches, and compliance with regulatory bodies are also covered to ensure robust research and patient safety. It is crucial that research institutions, pharmaceutical firms, and clinical centers work together to promote knowledge and accelerate therapeutic progress.
Participants will be provided with an understanding of the oncology trial methodology, conduct, and interpretation. This session stresses the central role of clinical studies in revolutionizing cancer treatment, enabling personalized treatments, enhancing patient outcomes, and driving the future of precision oncology.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
